(-)-demecolcine decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Demecolcine results in decreased expression of SLCO4C1 mRNA CTD PMID:23649840 1,1-dichloroethene decreases expression ISO Slco4c1 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of SLCO4C1 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO Slco4c1 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of SLCO4C1 mRNA CTD PMID:28960355 17beta-estradiol increases expression ISO SLCO4C1 (Homo sapiens) 6480464 Estradiol results in increased expression of SLCO4C1 mRNA CTD PMID:21185374 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slco4c1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLCO4C1 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLCO4C1 mRNA CTD PMID:20106945 more ... 2-palmitoylglycerol increases expression ISO SLCO4C1 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of SLCO4C1 mRNA CTD PMID:37199045 3-Iodothyronamine affects uptake ISO SLCO4C1 (Homo sapiens) 6480464 SLCO4C1 mRNA affects the uptake of 3-iodothyronamine CTD PMID:19074582 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLCO4C1 mRNA CTD PMID:16997883 8-Br-cAMP multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLCO4C1 mRNA CTD PMID:16997883 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of SLCO4C1 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO SLCO4C1 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of SLCO4C1 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO SLCO4C1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SLCO4C1 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of SLCO4C1 mRNA CTD PMID:21632981 more ... all-trans-retinoic acid increases expression ISO SLCO4C1 (Homo sapiens) 6480464 Tretinoin results in increased expression of SLCO4C1 mRNA CTD PMID:21934132 and PMID:33167477 amiodarone increases expression ISO SLCO4C1 (Homo sapiens) 6480464 Amiodarone results in increased expression of SLCO4C1 mRNA CTD PMID:19774075 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of SLCO4C1 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SLCO4C1 mRNA CTD PMID:33212167 atenolol increases expression ISO SLCO4C1 (Homo sapiens) 6480464 Atenolol results in increased expression of SLCO4C1 mRNA CTD PMID:19915711 azathioprine decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Azathioprine results in decreased expression of SLCO4C1 mRNA CTD PMID:22623647 belinostat increases expression ISO SLCO4C1 (Homo sapiens) 6480464 belinostat results in increased expression of SLCO4C1 mRNA CTD PMID:26272509 belinostat multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA CTD PMID:27188386 benzo[a]pyrene decreases expression ISO Slco4c1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SLCO4C1 mRNA CTD PMID:19770486 and PMID:21715664 benzo[a]pyrene increases methylation ISO SLCO4C1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLCO4C1 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO SLCO4C1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLCO4C1 3' UTR and Benzo(a)pyrene affects the methylation of SLCO4C1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLCO4C1 mRNA CTD PMID:20064835 more ... benzo[a]pyrene diol epoxide I decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLCO4C1 mRNA CTD PMID:25181051 butanal increases expression ISO SLCO4C1 (Homo sapiens) 6480464 butyraldehyde results in increased expression of SLCO4C1 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLCO4C1 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLCO4C1 mRNA CTD PMID:35301059 caffeine increases phosphorylation ISO SLCO4C1 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of SLCO4C1 protein CTD PMID:35688186 carbon nanotube affects expression ISO Slco4c1 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of SLCO4C1 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO Slco4c1 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of SLCO4C1 mRNA CTD PMID:25554681 chloroprene decreases expression ISO Slco4c1 (Mus musculus) 6480464 Chloroprene results in decreased expression of SLCO4C1 mRNA CTD PMID:23125180 cyclosporin A increases expression ISO Slco4c1 (Mus musculus) 6480464 Cyclosporine results in increased expression of SLCO4C1 mRNA CTD PMID:19770486 and PMID:25270620 cyclosporin A decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLCO4C1 mRNA CTD PMID:20106945 more ... dexamethasone multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLCO4C1 mRNA CTD PMID:16997883 dicrotophos decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 dicrotophos results in decreased expression of SLCO4C1 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO SLCO4C1 (Homo sapiens) 6480464 Doxorubicin affects the expression of SLCO4C1 mRNA CTD PMID:25529476 entinostat increases expression ISO SLCO4C1 (Homo sapiens) 6480464 entinostat results in increased expression of SLCO4C1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA CTD PMID:27188386 ethyl methanesulfonate decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLCO4C1 mRNA CTD PMID:23649840 folic acid decreases expression ISO Slco4c1 (Mus musculus) 6480464 Folic Acid results in decreased expression of SLCO4C1 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of SLCO4C1 mRNA CTD PMID:23649840 herbicide multiple interactions EXP 6480464 [Phytochemicals co-treated with Environmental Pollutants co-treated with Food Preservatives co-treated with Plasticizers co-treated with Sunscreening Agents co-treated with Insecticides co-treated with Fungicides and Industrial co-treated with Herbicides] inhibits the reaction [perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 protein] CTD PMID:25588985 hexane decreases methylation EXP 6480464 n-hexane results in decreased methylation of SLCO4C1 promoter CTD PMID:23740543 isotretinoin decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of SLCO4C1 mRNA CTD PMID:20436886 L-homoarginine increases export ISO SLCO4C1 (Homo sapiens) 6480464 SLCO4C1 protein results in increased export of Homoarginine CTD PMID:30865704 lipopolysaccharide multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLCO4C1 mRNA CTD PMID:35811015 lipopolysaccharide decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of SLCO4C1 mRNA CTD PMID:35811015 mercury dibromide multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA CTD PMID:27188386 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of SLCO4C1 mRNA CTD PMID:28536007 mercury dichloride decreases expression ISO Slco4c1 (Mus musculus) 6480464 Mercuric Chloride results in decreased expression of SLCO4C1 mRNA CTD PMID:27720909 methamphetamine increases expression ISO SLCO4C1 (Homo sapiens) 6480464 Methamphetamine results in increased expression of SLCO4C1 mRNA CTD PMID:25290377 methylmercury chloride decreases expression ISO Slco4c1 (Mus musculus) 6480464 methylmercuric chloride results in decreased expression of SLCO4C1 mRNA CTD PMID:27720909 methylmercury chloride decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SLCO4C1 mRNA CTD PMID:28001369 N(omega),N(omega)-dimethyl-L-arginine increases uptake ISO SLCO4C1 (Homo sapiens) 6480464 SLCO4C1 protein results in increased uptake of N and N-dimethylarginine CTD PMID:30865704 N-methyl-4-phenylpyridinium increases expression ISO SLCO4C1 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLCO4C1 mRNA CTD PMID:24810058 nickel atom decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Nickel results in decreased expression of SLCO4C1 mRNA CTD PMID:23195993 and PMID:24768652 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of SLCO4C1 mRNA CTD PMID:33484710 ozone multiple interactions ISO Slco4c1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLCO4C1 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid increases expression ISO SLCO4C1 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in increased expression of SLCO4C1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA CTD PMID:27188386 panobinostat increases expression ISO SLCO4C1 (Homo sapiens) 6480464 panobinostat results in increased expression of SLCO4C1 mRNA CTD PMID:26272509 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SLCO4C1 mRNA CTD PMID:32680482 perfluorononanoic acid decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 mRNA CTD PMID:32588087 perfluorononanoic acid multiple interactions EXP 6480464 [Phytochemicals co-treated with Environmental Pollutants co-treated with Food Preservatives co-treated with Plasticizers co-treated with Sunscreening Agents co-treated with Insecticides co-treated with Fungicides and Industrial co-treated with Herbicides] inhibits the reaction [perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 protein] CTD PMID:25588985 perfluorononanoic acid decreases expression EXP 6480464 perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 protein CTD PMID:25588985 perfluorooctane-1-sulfonic acid decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of SLCO4C1 mRNA CTD PMID:27153767 phenylmercury acetate increases expression ISO SLCO4C1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of SLCO4C1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA CTD PMID:27188386 pioglitazone multiple interactions ISO Slco4c1 (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLCO4C1 mRNA CTD PMID:27935865 potassium chromate increases expression ISO SLCO4C1 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of SLCO4C1 mRNA CTD PMID:22714537 quercetin decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Quercetin results in decreased expression of SLCO4C1 mRNA CTD PMID:21632981 raloxifene multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of SLCO4C1 mRNA CTD PMID:19059307 rifampicin increases expression ISO SLCO4C1 (Homo sapiens) 6480464 Rifampin results in increased expression of SLCO4C1 mRNA CTD PMID:27199754 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLCO4C1 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO SLCO4C1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of SLCO4C1 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO SLCO4C1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of SLCO4C1 mRNA CTD PMID:22714537 sodium arsenite decreases expression ISO Slco4c1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLCO4C1 mRNA CTD PMID:37682722 sulforaphane increases expression ISO SLCO4C1 (Homo sapiens) 6480464 sulforaphane results in increased expression of SLCO4C1 mRNA CTD PMID:26833863 sunitinib increases expression ISO SLCO4C1 (Homo sapiens) 6480464 Sunitinib results in increased expression of SLCO4C1 mRNA CTD PMID:31533062 tamoxifen multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of SLCO4C1 mRNA CTD PMID:19059307 thalidomide decreases expression ISO Slco4c1 (Mus musculus) 6480464 Thalidomide results in decreased expression of SLCO4C1 mRNA CTD PMID:26217789 titanium dioxide increases expression ISO Slco4c1 (Mus musculus) 6480464 titanium dioxide results in increased expression of SLCO4C1 mRNA CTD PMID:23557971 trichostatin A increases expression ISO SLCO4C1 (Homo sapiens) 6480464 trichostatin A results in increased expression of SLCO4C1 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA CTD PMID:27188386 triphenyl phosphate increases expression ISO SLCO4C1 (Homo sapiens) 6480464 triphenyl phosphate results in increased expression of SLCO4C1 mRNA CTD PMID:28934090 valproic acid affects expression ISO SLCO4C1 (Homo sapiens) 6480464 Valproic Acid affects the expression of SLCO4C1 mRNA CTD PMID:25979313 valproic acid increases expression ISO SLCO4C1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLCO4C1 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA CTD PMID:27188386 vincristine decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 Vincristine results in decreased expression of SLCO4C1 mRNA CTD PMID:23649840 vorinostat multiple interactions ISO SLCO4C1 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4C1 mRNA CTD PMID:27188386 vorinostat increases expression ISO SLCO4C1 (Homo sapiens) 6480464 vorinostat results in increased expression of SLCO4C1 mRNA CTD PMID:26272509 zoledronic acid decreases expression ISO SLCO4C1 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of SLCO4C1 mRNA CTD PMID:24714768